-
Founded in:
2000-05-31 -
Country:
China -
Address:
No. 469, Qilian Road, Chengbei District, Xining City, Qinghai Province -
Tax NO.:
91630000226580626R -
Registered Funds:
100 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metronidazole |
1. It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobic bacteria. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. 2. It can inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can change its morphology in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. 3. It has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals.
More
1. It has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobic bacteria. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. 2. It can inhibit the redox reaction of amoeba and break the nitrogen chain of protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytica can change its morphology in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytica can be killed within 72 hours. 3. It has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals. |
443-48-1 | 39 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ciprofloxacin hydrochloride |
It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It has antibacterial activity against most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
It has a broad-spectrum antibacterial effect, especially against aerobic Gram-negative bacteria. It has antibacterial activity against most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. It acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
93107-08-5 | 37 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CALCIUM GLUCONATE MONOHYDRATE |
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability
More
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability |
160mg | 66905-23-5 | 35 |
| Calcium phosphate dibasic |
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability
More
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability |
9.2mg | 7757-93-9 | 16 |
| Sodium 3-phosphoglycerate |
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability
More
Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and reduces capillary permeability |
2mg | 17603-42-8 | 9 |
| Riboflavin |
Essential substances for maintaining normal metabolism and growth and development of the body
More
Essential substances for maintaining normal metabolism and growth and development of the body |
0.096mg | 83-88-5 | 19 |
| Vitamin D2 |
Essential substances for maintaining normal metabolism and growth and development of the body
More
Essential substances for maintaining normal metabolism and growth and development of the body |
2.25microgram | 50-14-6 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Nefopam hydrochloride |
This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. Its chemical structure belongs to cyclized o-methylbenzylamine. Therefore, it does not have the characteristics of non-steroidal anti-inflammatory drugs, nor is it an opioid receptor agonist. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence.
More
This product is a new type of non-narcotic analgesic, with mild antipyretic and muscle relaxant effects. Its chemical structure belongs to cyclized o-methylbenzylamine. Therefore, it does not have the characteristics of non-steroidal anti-inflammatory drugs, nor is it an opioid receptor agonist. It is effective for moderate and severe pain. An intramuscular injection of 20 mg of this product is equivalent to the effect of 12 mg of morphine. It has a mild respiratory depressant effect. It has no depressant effect on the circulatory system. There is no tolerance and dependence. |
23327-57-3 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acetaminophen |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve an antipyretic effect; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and has an analgesic effect. It is a peripheral analgesic, weaker than aspirin, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
126mg | 103-90-2 | 68 |
| Acetylsalicylic acid |
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve the effect of antipyretic; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and plays an analgesic role. It is a peripheral analgesic, with a stronger effect than acetaminophen, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect.
More
By inhibiting cyclooxygenase, it selectively inhibits the synthesis of prostaglandins in the hypothalamic temperature regulation center, leading to peripheral vasodilation and sweating to achieve the effect of antipyretic; by inhibiting the synthesis and release of prostaglandins, it increases the pain threshold and plays an analgesic role. It is a peripheral analgesic, with a stronger effect than acetaminophen, and is only effective for mild and moderate pain. This product has no obvious anti-inflammatory effect. |
230mg | 50-78-2 | 35 |
| Caffeine |
Auxiliary enhancement of antipyretic and analgesic effects.
More
Auxiliary enhancement of antipyretic and analgesic effects. |
30mg | 0 |